Wednesday, February 24, 3:30-5 p.m. in the Marburg Conference Room

“Testosterone and 'Age-Related Hypogonadism' - FDA Concerns”

  • Hylton Joffe, director, Division of Bone, Reproductive and Urologic Products, FDA
  • Mohamed Mohamoud, team leader, Drug Utilization Team, Division of Epidemiology, FDA
  • Trung-Hieu Brian Tran, regulatory review officer, Office of Prescription Drug Promotion
  • Mark Hirsch, clinical team leader, Division of Bone, Reproductive and Urologic Products, FDA
  • David Moeny, deputy director, Division of Epidemiology II, FDA
  • Christine Nguyen, deputy director for safety, Division of Bone, Reproductive and Urologic Products, FDA
Share This Post